Knowing that patients with posttraumatic stress disorder and substance use disorder share impaired prefrontal cortex regulation, particularly at glutamate synapses in the nucleus accumbens, the authors conducted this first-ever RCT to investigate whether N-acetylcysteine would be a viable pharmacologic treatment for veterans with comorbid PTSD and SUD. Was the result all they were hoping for?